Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Endocrinol ; 258(1)2023 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-37078922

RESUMO

Leukaemia inhibitory factor (LIF) is a cytokine belonging to the interleukin-6 family that is important at the reproductive level in the uterine implantation process. However, there is very little evidence regarding its effect at the ovarian level. The aim of this work was to study the local involvement of the LIF/LIFRß system in follicular development and steroidogenesis in rat ovaries. To carry out this research, LIF/LIFR/GP130 transcript and protein levels were measured in fertile and sub-fertile rat ovaries, and in vitro experiments were performed to assess STAT3 activation. Then, in in vivo experiments, LIF was administered chronically and locally for 28 days to the ovaries of rats by means of an osmotic minipump to enable us to evaluate the effect on folliculogenesis and steroidogenesis. It was determined by quantitative polymerase chain reaction and western blot that LIF and its receptors are present in fertile and sub-fertile ovaries and that LIF varies during the oestrous cycle, being higher during the oestrus and meta/dioestrus stages. In addition to this, it was found that LIF can activate STAT3 pathways and cause pSTAT3 formation. It was also observed that LIF decreases the number and size of preantral and antral follicles without altering the number of atretic antral follicles and can increase the number of corpora lutea, with a notable increase in the levels of progesterone (P4). It is therefore possible to infer that LIF exerts an important effect in vivo on folliculogenesis, ovulation and steroidogenesis, specifically the synthesis of P4.


Assuntos
Folículo Ovariano , Ovário , Feminino , Ratos , Animais , Fator Inibidor de Leucemia/farmacologia , Corpo Lúteo , Ovulação
2.
Domest Anim Endocrinol ; 45(3): 126-40, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23972491

RESUMO

Cystic ovarian disease (COD) is an important cause of infertility in cattle, and ACTH has been involved in regulatory mechanisms related to ovarian function associated with ovulation, steroidogenesis, and luteal function. Here, we examined the localization of 11ß-hydroxysteroid dehydrogenase type 1 (11ßHSD1) and 11ßHSD2 proteins in the ovary of healthy cows and animals with spontaneous and ACTH-induced COD and the in vitro response of the follicular wall exposed to ACTH. After stimulation by ACTH, we documented changes in 11ßHSD expression and cortisol secretion by the follicular wall of large antral and follicular cysts. Follicular cysts showed a higher constitutive expression of both enzymes, whereas ACTH induced an increase in 11ßHSD1 in tertiary follicles and follicular cysts and a decrease in 11ßHSD2 in follicular cysts. Moderate expression of 11ßHSD1 was observed by immunohistochemistry in granulosa of control animals, with an increase (P < 0.05) from primary to secondary, tertiary, and atretic follicles. The level of immunostaining in theca interna was lower than that in granulosa. The expression of 11ßHSD2 was lower in the granulosa of primary follicles than in that of secondary, tertiary, and atretic follicles and was lower in the theca interna than in the granulosa. In ACTH-induced and spontaneously occurring follicular cysts, differences from controls were observed only in the expression of 11ßHSD1 in the granulosa, being higher (P < 0.05) than in tertiary follicles. These findings indicate that follicular cysts may be exposed to high local concentrations of active glucocorticoids and indicate a local role for cortisol in COD pathogenesis and in regulatory mechanisms of ovarian function.


Assuntos
11-beta-Hidroxiesteroide Desidrogenases/análise , Hormônio Adrenocorticotrópico/farmacologia , Doenças dos Bovinos/enzimologia , Cistos Ovarianos/veterinária , Ovário/enzimologia , Animais , Bovinos , Doenças dos Bovinos/patologia , Estradiol/sangue , Feminino , Células da Granulosa/enzimologia , Hidrocortisona/sangue , Imuno-Histoquímica , Microscopia Eletrônica de Varredura/veterinária , Cistos Ovarianos/induzido quimicamente , Cistos Ovarianos/enzimologia , Folículo Ovariano/enzimologia , Folículo Ovariano/metabolismo , Folículo Ovariano/patologia , Progesterona/sangue , Testosterona/sangue , Ultrassonografia/veterinária
3.
Horm Metab Res ; 44(9): 682-7, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22407436

RESUMO

As aging proceeds, fertility problems arise, and the success rate of in vitro fertilization declines. During reproductive aging, rat ovaries present spontaneous formation of cysts, followed by a concomitant increase in sympathetic nerve activity, causing infertility and cessation of ovarian function. ß2-Adrenergic receptors, which are activated by noradrenaline (NA), modify follicular development and steroid secretions; thus, increased nerve activity has been associated with the development and maintenance of cystic structures. The purpose of this work was to block the effect of this sympathetic activity through in vivo administration of propranolol (a ß-adrenergic receptor antagonist) to determine whether it delays cyst formation and cessation of the ovarian function in rats that had reached the subfertile period. Propranolol was administrated daily to 8- and 10-month-old rats for 2 months. Estrous cycling activity was monitored by vaginal smear, serum concentration of the steroidal hormones was determined by enzyme-immune assay and morphological analysis of the ovaries was performed using 6 µm tissue slices stained with hematoxylin-eosin. Propranolol increased the number of healthy follicles, the ovulation rate, and levels of serum sexual steroids (androstenedione, testosterone, and estradiol) and recovered estrous cycling activity. It also decreased the number of follicular cysts. These results suggest that the blockade of ß-adrenergic receptors recovered ovarian function during reproductive aging. It is suggested that propranolol induces a time-dependent extension of the subfertile window, and it could be used to increase the success rate of fertility programs in aging woman.


Assuntos
Antagonistas de Receptores Adrenérgicos beta 2/administração & dosagem , Período Fértil/efeitos dos fármacos , Cistos Ovarianos/tratamento farmacológico , Propranolol/administração & dosagem , Animais , Regulação para Baixo/efeitos dos fármacos , Feminino , Humanos , Ciclo Menstrual/efeitos dos fármacos , Cistos Ovarianos/genética , Cistos Ovarianos/metabolismo , Cistos Ovarianos/fisiopatologia , Folículo Ovariano/efeitos dos fármacos , Folículo Ovariano/metabolismo , Folículo Ovariano/fisiopatologia , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos beta 2/genética , Receptores Adrenérgicos beta 2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA